Integration of Antiretroviral Therapy with Tuberculosis Treatment
Salim S Abdool Karim, Kogieleum Naidoo, Anneke Grobler, Nesri Padayatchi, Cheryl Baxter, Andrew L Gray, Tanuja Gengiah, Santhanalakshmi Gengiah, Anushka Naidoo, Niraksha Jithoo, Gonasagrie Nair, Wafaa M El-Sadr, Gerald Friedland, Quarraisha Abdool Karim
New England Journal of Medicine | MASSACHUSETTS MEDICAL SOC | Published : 2011
Supported by the U.S. President's Emergency Plan for AIDS Relief; the Centre for the AIDS Programme of Research in South Africa (CAPRISA); the Global Fund to Fight AIDS, Tuberculosis, and Malaria; and the National Institutes of Health Comprehensive International Program of Research on AIDS.We thank the patients for their participation in this study; Prof. Willem Sturm of the Nelson R. Mandela School of Medicine for confirmatory tuberculosis testing; the management and staff of the Prince Cyril Zulu Communicable Disease Clinic, eThekwini Municipality, for support of the study; Drs. Gray Handley, Ed Tramont, Rod Hoff, Sandi Lehrman, and Richard Hafner of the Division of AIDS at the National Institutes of Health for study support; Drs. Gavin Churchyard, Douglas Taylor, and Mark Weaver for serving on the data and safety monitoring committee; members of the Community Advisory Board for their advice regarding the conduct of the trial; Ms. Nomapando Barnabas of the CAPRISA Community Programme for overseeing community involvement in the trial; Ms. Natasha Samsunder and Mr. Keith Coetzee for laboratory analysis; Ms. Nonhlanhla Yende for statistical support; Ms. Irene van Middelkoop for data management; and all the other members of the SAPIT study team for their commitment to high-quality study conduct.